OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Apelin/APJ System in Psychosis and Neuropathy
Shuangyu Lv, Weidong Chen, Yan‐Dong Wang
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Intrathecally Administered Apelin-13 Alleviated Complete Freund’s Adjuvant-Induced Inflammatory Pain in Mice
Shuangyu Lv, Xiaomei Zhang, Yuchen Zhou, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 10

Relationship between Apelin/APJ Signaling, Oxidative Stress, and Diseases
Shuangyu Lv, Yu Feng, Qiying Jiang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 9

Apelin–13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male rats
Sara Gazmeh, Maryam Azhir, Leila Elyasi, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 3, pp. 701-709
Closed Access | Times Cited: 6

Apelin-13 attenuates depressive-like behaviors induced by chronic unpredictable mild stress via activating AMPK/PGC-1α/FNDC5/BDNF pathway
Sheng Hu, Lu He, Bin Chen, et al.
Peptides (2022) Vol. 156, pp. 170847-170847
Closed Access | Times Cited: 6

Apelin-Overexpressing Neural Stem Cells in Conjunction with a Silk Fibroin Nanofiber Scaffold for the Treatment of Traumatic Brain Injury
Tianwen Li, Qisheng Tang, Jiaxin Xu, et al.
Stem Cells and Development (2023) Vol. 32, Iss. 17-18, pp. 539-553
Closed Access | Times Cited: 2

The regulatory effects of the apelin/APJ system on depression: A prospective therapeutic target
Yanjun Tian, Ruihao Wang, Lin Liu, et al.
Neuropeptides (2023) Vol. 102, pp. 102382-102382
Open Access | Times Cited: 2

High APLN Expression Predicts Poor Prognosis for Glioma Patients
Shuangyu Lv, Yang An, Huan Dong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 4

Evidence for the induction of analgesic cross-tolerance between opioid and apelin/APJ systems in male rats
Elham Abbasloo, Saeed Esmaeili‐Mahani, Firas Kobeissy, et al.
Journal of Studies on Alcohol and Drugs (2024) Vol. 85, Iss. 5, pp. 704-712
Closed Access

A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders
Youcheng Zhang, Vinay Srinivas Bharadhwaj, Alpha Tom Kodamullil, et al.
Discover Mental Health (2024) Vol. 4, Iss. 1
Open Access

Bioinformatics Screening and Experimental Validation for Deciphering the Immune Signature of Late-Onset Depression
Xinxia Wang, Yao Gao, Dan Wang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2347-2361
Open Access

The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
Maryam Azhir, Sara Gazmeh, Leila Elyasi, et al.
Yādgār. (2023) Vol. 7, Iss. 4, pp. 15-19
Closed Access | Times Cited: 1

Research progress of apelin in acute ischemic brain injury.
Huaiqing Luo, Xiaoyong Gu, Guoxiang Tong, et al.
PubMed (2022) Vol. 14, Iss. 10, pp. 7260-7267
Closed Access | Times Cited: 2

Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia
Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Adam Wysokiński, et al.
Journal of Investigative Medicine (2021) Vol. 69, Iss. 1, pp. 56-65
Closed Access | Times Cited: 2

Potential of Heterogeneous Compounds as Antidepressants: A Narrative Review
Gonghui Hu, Meng Zhang, Yuyang Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13776-13776
Open Access | Times Cited: 1

SERUM APELIN-13 LEVELS ARE DECREASED AMONG ADOLESCENTS DIAGNOSED WITH MAJOR DEPRESSIVE DISORDER
Sadettin Burak Açıkel, Abdülbaki Artık, Esra Hosoglu, et al.
Psychiatria Danubina (2022) Vol. 34, Iss. 4, pp. 677-681
Open Access | Times Cited: 1

Neuronetworks: Analysis of brain pathology in Mucopolysaccharidoses – A systems biology approach
Gerda Cristal Villalba Silva, Úrsula da Silveira Matte
Neuroscience Informatics (2021) Vol. 2, Iss. 1, pp. 100036-100036
Open Access | Times Cited: 1

A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders
Youcheng Zhang, Vinay Srinivas Bharadhwaj, Alpha Tom Kodamullil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Tsukushi proteoglycan maintains RNA splicing and developmental signaling network in GFAP-expressing subventricular zone neural stem/progenitor cells
Arif Istiaq, Terumasa Umemoto, Naofumi Ito, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access

RECENT ADVANCES IN THE DEVELOPMENT OF SMALL-MOLECULE APELIN RECEPTOR AGONISTS FOR CARDIOVASCULAR AND METABOLIC DISEASES
Sanju Narayanan, Rajendra Uprety, Rangan Maitra, et al.
Medicinal chemistry reviews (2022), pp. 95-115
Closed Access

Previous Page - Page 2

Scroll to top